[BHVN] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[BHVN] Biohaven Pharmaceutical Holding Company Ltd.
Announcement Date
14-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -13.53%
YoY- -48.98%
Quarter Report
BHVN's Result
BHVN's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 0 0 135,740 17,664 0 0 0 -
PBT -105,861 -67,637 -55,497 -192,639 -105,844 -61,280 -42,860 16.25%
Tax -3,287 1,216 -1,132 3,989 323 161 55 -
NP -102,574 -68,853 -54,365 -195,189 -106,167 -61,441 -42,915 15.62%
Tax Rate - - - - - - - -
Total Cost 102,574 68,853 190,105 212,853 106,167 61,441 42,915 15.62%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin 0.00 0.00 -40.05 -1,105.01 0.00 0.00 0.00 -
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -1.50 -1.75 -1.52 -3.27 -2.04 -1.53 -1.19 3.93%
EPS Diluted -1.50 -1.75 -1.52 -3.27 -2.04 -1.53 -1.19 3.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.